India prednisolone market is expected to grow at a steady rate during the forecast period. The India prednisolone market is driven by high use of this medication to treat a number of inflammatory and autoimmune conditions such as asthma, uveitis, pyoderma gangrenosum, rheumatoid arthritis, among others. Additionally, the drug is also used as an immunosuppressive drug for organ transplants which is further expected to boost the demand through FY2026. Improvement in healthcare infrastructure is further predicted to bolster the market growth in the years to come.
The India prednisolone market is segmented based on form, route of administration, distribution channel, source, application, end user, company, and region. Based on form, the market is segmented into capsule, tablet, injection, syrup, eye drops. Among them, the tablet segment dominated the market until 2019 and is further projected to maintain its dominance in the market during the forecast years as well on account of their longer shelf life than other alternatives present in the market. Also, the capsule segment is anticipated to grow at a high CAGR in the market over the next five years because capsules are fast-acting and
The major players operating in the India prednisolone market are Cipla Ltd., Avik Pharmaceutical Limited, Anuh Pharma Ltd., Neon Laboratories Limited, Psychotropics India Limited, Nicholas Piramal India Ltd., Mankind Pharma Pvt. Ltd., Macleods Pharmaceuticals Ltd., Allergan India Pvt. Ltd., Sanofi Aventis Pharma India Ltd., and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive
Years considered for this report
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze and estimate the market size of India Prednisolone market from FY2016 to FY2019.
- To estimate and forecast the market size of India prednisolone market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India prednisolone market based on form, route of administration, distribution channel, source, application, end user, company, and regional distribution.
- To identify dominant region or segment in the India prednisolone market.
- To identify drivers and challenges for India prednisolone market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India prednisolone market.
- To identify and analyze the profile of leading players operating in India prednisolone market.
- To identify key sustainable strategies adopted by market players in India prednisolone market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Prednisolone manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to prednisolone
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
